Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
New England Journal of Medicine · 06.02.2025 · 392 (6) · 521-523
DOI: 10.1056/nejmp2412955 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 06.02.2025. Verfasst von Joseph S Ross. Beteiligte Einrichtung: Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
- Department of Health Policy and Management, Yale School of Public Health, New Haven, CT.
- Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, CT.
ORCID-Profile: Joseph S Ross
Zitieren
APA
Ross, J. S. (2025). Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries. New England Journal of Medicine, 392(6), 521-523. https://doi.org/10.1056/nejmp2412955
Vancouver
Ross JS. Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries. New England Journal of Medicine. 2025;392(6):521-523. doi:10.1056/nejmp2412955
BibTeX
@article{Ross2025,
author = {Ross, Joseph S},
title = {Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {6},
pages = {521--523},
doi = {10.1056/nejmp2412955}
}
EUVIMED